Statistics for Theralase Technologies Inc (id:1389 TLT)
Valuation metrics
Market cap
61.94M
Enterprise value
72.76M
Trailing P/E (ttm)
-11.82
Forward P/E
-25.00
PEG ratio
-25.00
Price/Sales (ttm)
67.29
Price/Book (mrq)
31.25
Enterprise Value/Revenue
79.03
Enterprise Value/EBITDA
-17.13
Overview
Shares outstanding
247.78M
Float
226.03M
Shares short
9.86K
% Held by insiders
5.00%
% Held by institutions
0.00%
Average volume (10 days)
63.35K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
3.00
52-Week change
34.62%
Beta
1.35
50-Day moving average
3.00
200-Day moving average
3.00
Dividends and splits
Forward annual dividend rate
1.62
Forward annual dividend yield
6.23
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
December 29, 2008
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
52.52%
Operating margin
-1,130.41%
Operational effectiveness
Return on assets
-81.88%
Return on equity
-238.55%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
562.13K
EBITDA
-4,246,953.00
Net income to common (ttm)
-4,407,153.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
428.36K
Total cash per share (mrq)
5.00
Total debt (mrq)
341.18K
Total Debt/Equity (mrq)
20.58
Current ratio (mrq)
121.20%
Book value per share (mrq)
5.00
Cash flow
Cash flow statement
-3,338,621.00
Levered free cash flow (LFCF)
-1,609,963.00